Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other emerging Asia Pacific markets. The company has built a portfolio of potentially first-in-class or best-in-class molecules, many of which are in late-stage clinical development or already approved. Their therapeutic areas of focus include oncology, immunology, cardio-renal disease, and infectious diseases, aiming to bring innovative therapies to patients swiftly and efficiently.
Serves as the core operational hub, overseeing strategic planning, research and development collaborations, clinical operations, commercial strategy, and corporate functions for the Asia Pacific region.
Situated in the Shanghai Tower, one of the world's tallest and most iconic skyscrapers, offering advanced infrastructure and a prestigious business environment.
The headquarters likely fosters a dynamic, fast-paced, and collaborative work culture, emphasizing scientific rigor, innovation, and a patient-centric approach to drug development and commercialization.
Its Shanghai location provides access to a rich ecosystem of academic institutions, clinical research organizations, talent, and proximity to key regulatory bodies and market opportunities in China.
Everest Medicines has established a strategic presence focused on Greater China and other emerging Asia Pacific markets. While its core operations are centered in China (Shanghai, Beijing, Suzhou), it maintains international offices in the USA (Princeton) and Singapore to support global business development, licensing, clinical collaborations, and access to international innovation and capital markets. This network enables them to source global innovations and bring them to patients in their target regions.
Level 30, Shanghai Tower, 501 Yincheng Middle Road, Pudong New Area
Shanghai
Shanghai
China
Address: Unit 06-07, 35F, China World Tower A, No.1 Jianguomenwai Avenue, Chaoyang District, Beijing, China
Facilitates engagement with key national stakeholders and supports operations in Northern China.
Address: Building C19, BioBAY, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Province, China
Drives R&D activities and innovation within a specialized biotech ecosystem.
Address: 100 Overlook Center, Suite 102, Princeton, NJ 08540, USA
Facilitates international collaborations, licensing activities, and access to the US market and talent pool.
Address: 18 Sct Jean-Baptiste Say, Singapore 188493
Supports expansion and operations in key Southeast Asian markets, leveraging Singapore's position as a regional business and biotech hub.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Everest Medicines' leadership includes:
Everest Medicines has been backed by several prominent investors over the years, including:
Everest Medicines has seen key leadership appointments and transitions aimed at strengthening its scientific, commercial, and operational capabilities as it advances its pipeline and expands its market presence. Notably, a new Chief Scientific Officer was appointed in mid-2023.
Discover the tools Everest Medicines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Everest Medicines commonly uses the [first_initial][last] or [first].[last] email format. For example, an employee named Jane Doe might have an email address like jdoe@everestmedicines.com or jane.doe@everestmedicines.com.
[first_initial][last]@everestmedicines.com
Format
rluo@everestmedicines.com
Example
80%
Success rate
Everest Medicines Press Release / Business Wire • May 21, 2024
Everest Medicines announced positive topline results from the Phase 3 clinical trial of Nefecon® in Chinese patients with IgA Nephropathy (IgAN). The study met its primary efficacy endpoint, showing a statistically significant improvement in kidney function as measured by estimated glomerular filtration rate (eGFR) compared to placebo....more
Everest Medicines Press Release / Business Wire • March 26, 2024
Everest Medicines reported its 2023 financial results, highlighting product revenue growth driven by Nefecon® and Xerava®. The company emphasized progress in its pipeline, upcoming regulatory milestones, and commercial expansion plans for its key assets in Greater China and Asia....more
Everest Medicines Press Release / Business Wire • February 29, 2024
Everest Medicines issued a positive profit alert, expecting to record a significant increase in profit for the full year ended December 31, 2023, primarily due to increased revenue from product sales and disciplined cost management....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Everest Medicines, are just a search away.